River Stone Overview

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 1

River Stone General Information

Description

Owner and operator of an integrated synthetic biology company intended to improve the production and performance of pharmaceuticals. The company focuses on areas such as molecules from synthetic chemistry, manufacturing processes, tissue targeting, tissue absorption, and related regions, enabling clients to produce affordable, higher-purity, and specific enantiomers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 251 Little Falls Drive
  • Wilmington County of New Castle
  • New Castle, DE 19808
  • United States
Primary Industry
Specialty Chemicals
Vertical(s)
Corporate Office
  • 251 Little Falls Drive
  • Wilmington County of New Castle
  • New Castle, DE 19808
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

River Stone Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC Completed Generating Revenue
2. Secondary Transaction - Private 01-May-2017 Completed Generating Revenue
1. Early Stage VC 01-Mar-2015 Completed Startup
To view River Stone’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

River Stone Patents

River Stone Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026180695-A1 Method for producing noroxymorphone and bioactive derivatives thereof Pending 28-Feb-2025
WO-2026099311-A2 Microbial cell factories producing prostaglandins Pending 05-Nov-2024
WO-2026099311-A3 Microbial cell factories producing prostaglandins Pending 05-Nov-2024
AU-2024216696-A1 Improved synthesis of buprenorphine, analogues and intermediates Pending 08-Feb-2023
EP-4662216-A1 Improved synthesis of buprenorphine, analogues and intermediates Pending 08-Feb-2023 C07D489/04
To view River Stone’s complete patent history, request access »

River Stone Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Double Bioventures Venture Capital Minority
To view River Stone’s complete investors history, request access »

River Stone FAQs

  • Where is River Stone headquartered?

    River Stone is headquartered in New Castle, DE.

  • What industry is River Stone in?

    River Stone’s primary industry is Specialty Chemicals.

  • Is River Stone a private or public company?

    River Stone is a Private company.

  • What is River Stone’s current revenue?

    The current revenue for River Stone is .

  • Who are River Stone’s investors?

    Double Bioventures has invested in River Stone.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process